Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours Β· Estimated delivery Aug 19 - Aug 24
WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
In severe circumstances, liver transplantation is the only option that might possibly save the patients life
GLP-1 medications like semaglutide (Wegovy, Ozempic) or the dual agonist tirzepatide (Zepbound, Mounjaro) reduce appetite and slow gastric emptying, making it easier to eat less without constant hunger
Slowing gastric emptying: GLP-1 agonists delay the rate at which the stomach empties its contents into the small intestine
US$ 26.68
US$ 23.02
US$ 21.97
US$ 22.22
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 27.87
US$ 26.65
US$ 20.64
